Differential effects of LY294002 and Wortmannin on neurons and vascular endothelial cells in the rat retina

Pharmacological Reports

Volumn 65, Issue 4, 2013, Pages 854-862

  Ueda, Kaori ^a   Nakahara, Tsutomu ^a   Akanuma, Kaori ^a   Mori, Asami ^a   Sakamoto, Kenji ^a   Ishii, Kunio ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Excitotoxicity; Glutamate; Phosphatidylinositol 3 kinase (PI3K) Akt signaling pathway; Retinal blood vessel; Retinal neuron

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; N METHYL DEXTRO ASPARTIC ACID; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL LOSS; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HISTOPATHOLOGY; MALE; NEUROPROTECTION; NONHUMAN; RAT; RETINA CAPILLARY; RETINA GANGLION CELL; RETINA INJURY; RETINA NERVE CELL;

ANDROSTADIENES; ANIMALS; CELL COUNT; CHROMONES; ENDOTHELIAL CELLS; INTRAVITREAL INJECTIONS; MALE; MORPHOLINES; N-METHYLASPARTATE; PROTEIN KINASE INHIBITORS; RATS; RETINAL DEGENERATION; RETINAL GANGLION CELLS;

EID: 84886510606     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71066-1     Document Type: Article

References (39)

1. Adachi K, Kashii S, Masai H, Ueda M, Morizane C, Kaneda K, Kume T et al.: Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch Clin Exp Ophthalmol, 1998, 236, 766-774.
2. Aki T, Mizukami Y, Oka Y, Yamaguchi K, Uemura K, Fujimiya T, Yoshida K: Phosphoinositide 3-kinase accelerates necrotic cell death during hypoxia. Biochem J, 2001, 358, 481-487.
3. Aki T, Yamaguchi K, Fujimiya T, Mizukami Y: Phosphoinositide 3-kinase accelerates autophagic cell death during glucose deprivation in the rat cardiomyocytederived cell line H9c2. Oncogene, 2003, 22, 8529-8535.
4. Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, El-Remessy AB: Neurovascular protective effect of FeTPPs in N-methyl-D-Aspartate model: similarities to diabetes. Am J Pathol, 2010, 177, 1187-1197.
5. Ambati J, Chalam KV, Chawla DK, D'Angio CT, Guillet EG, Rose SJ, Vanderlinde RE, Ambati BK: Elevated g-Aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with pro- liferative diabetic retinopathy. Arch Ophthalmol, 1997, 115, 1161-1166.
6. Avni D, Glucksam Y, Zor T: The phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 modulates cytokine expression in macrophages via p50 nuclear factor kB inhibition, in a PI3K-independent mechanism. Biochem Pharmacol, 2012, 83, 106-114.
7. Brunet A, Datta SR, Greenberg ME: Transcriptiondependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol, 2001, 11, 297-305.
8. Carbott DE, Duan L, Davis MA: Phosphoinositol 3 kinase inhibitor, LY294002 increases bcl-2 protein and inhibits okadaic acid-induced apoptosis in Bcl-2 expressing renal epithelial cells. Apoptosis, 2002, 69-76.
9. Crowder RJ, Freeman RS: The survival of sympathetic neurons promoted by potassium depolarization, but not by cyclic AMP, requires phosphatidylinositol 3-kinase and Akt. J Neurochem, 1999, 73, 466-475.
10. De La Cruz JP, Gonzalez-Correa JA, Guerrero A, de la Cuesta FS: Pharmacological approach to diabetic retinopathy. Diabetes Metab Res Rev, 2004, 20, 91-113.
11. Dkhissi O, Chanut E, Wasowicz M, Savoldelli M, Nguyen-Legros J, Minvielle F, Versaux-Botteri C: Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder. Invest Ophthalmol Vis Sci, 1999, 40, 990-995.
12. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA: Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol, 1996, 114, 299-305.
13. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA et al.: Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science, 1997, 275, 661-665.
14. Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP, Stefansson E: The impact of ocular blood flow in glaucoma. Prog Retin Eye Res, 2002, 21, 359-393.
15. Ghirlanda G, Di Leo MA, Caputo S, Cercone S, Greco AV: From functional to microvascular abnormalities in early diabetic retinopathy. Diabetes Metab Rev, 1997, 13, 15-35.
16. Grieshaber MC, Flammer J: Blood flow in glaucoma. Curr Opin Ophthalmol, 2005, 16, 79-83.
17. Huang Y, Cen LP, Luo JM, Wang N, Zhang MZ, van Rooijen N, Pang CP, Cui Q: Differential roles of phosphatidylinositol 3-kinase/akt pathway in retinal ganglion cell survival in rats with or without acute ocular hypertension. Neuroscience, 2008, 153, 214-225.
18. Izumi Y, Hammerman SB, Kirby CO, Benz AM, Olney JW, Zorumski CF: Involvement of glutamate in ischemic neurodegeneration in isolated retina. Vis Neurosci, 2003, 20, 97-107.
19. Kwong JM, Lam TT: N-methyl-D-Aspartate (NMDA) induced apoptosis in adult rabbit retinas. Exp Eye Res, 2000, 71, 437-444.
20. Lam TT, Abler AS, Kwong JM, Tso MO: N-methyl-Daspartate (NMDA)-induced apoptosis in rat retina. Invest Ophthalmol Vis Sci, 1999, 40, 2391-2397.
21. Lam TT, Siew E, Chu R, Tso MO: Ameliorative effect of MK-801 on retinal ischemia. J Ocul Pharmacol Ther, 1997, 13, 129-137.
22. Luo JM, Cen LP, Zhang XM, Chiang SW, Huang Y, Lin D, Fan YM et al.: PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury. Eur J Neurosci, 2007, 26, 828-842.
23. Manabe S, Lipton SA: Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina. Invest Ophthalmol Vis Sci, 2003, 44, 385-392.
24. Mori A, Ishii T, Kuroki T, Shigeta N, Sakamoto K, Nakahara T, Ishii K: The prostanoid EP2 receptor agonist ONO-AE1-259-01 protects against glutamateinduced neurotoxicity in rat retina. Eur J Pharmacol, 2009, 616, 64-67.
25. Nakazawa T, Shimura M, Endo S, Takahashi H, Mori N, Tamai M: N-Methyl-D-Aspartic acid suppresses Akt activity through protein phosphatase in retinal ganglion cells. Mol Vis, 2005, 11, 1173-1182.
26. Nakazawa T, Shimura M, Tomita H, Akiyama H, Yoshioka Y, Kudou H, Tamai M: Intrinsic activation of PI3K/Akt signaling pathway and its neuroprotective effect against retinal injury. Curr Eye Res, 2003, 26, 55-63.
27. Nakazawa T, Takahashi H, Nishijima K, Shimura M, Fuse N, Tamai M, Hafezi-Moghadam A, Nishida K: Pitavastatin prevents NMDA-induced retinal ganglion cell death by suppressing leukocyte recruitment. J Neurochem, 2007, 100, 1018-1031.
28. Ng YK, Zeng XX, Ling EA: Expression of glutamate receptors and calcium-binding proteins in the retina of streptozotocin-induced diabetic rats. Brain Res, 2004, 1018, 66-72.
29. Nucci C, Tartaglione R, Rombolà L, Morrone LA, Fazzi E, Bagetta G: Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxicology, 2005, 26, 935-941.
30. Park K, Luo JM, Hisheh S, Harvey AR, Cui Q: Cellular mechanisms associated with spontaneous and ciliary neurotrophic factor-cAMP-induced survival and axonal regeneration of adult retinal ganglion cells. J Neurosci, 2004, 24, 10806-10815.
31. Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham R, Ashendel C, Zalkow L et al.: Wortmannin, a potent and selective inhibitor of phosphatidylinositol- 3-kinase. Cancer Res, 1994, 54, 2419-2423.
32. Pulido JE, Pulido JS, Erie JC, Arroyo J, Bertram K, Lu MJ, Shippy SA: A role for excitatory amino acids in diabetic eye disease. Exp Diabetes Res, 2007, 2007, 36150.
33. Schmetterer L, Wolzt M: Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia, 1999, 42, 387-405.
34. Ueda K, Nakahara T, Hoshino M, Mori A, Sakamoto K, Ishii K: Retinal blood vessels are damaged in a rat model of NMDA-induced retinal degeneration. Neurosci Lett, 2010, 485, 55-59.
35. Ueda K, Nakahara T, Mori A, Sakamoto K, Ishii K: Protective effects of TGF-b inhibitors in a rat model of NMDA-induced retinal degeneration. Eur J Pharmacol, 2013, 699, 188-193.
36. Vlahos CJ, Matter WF, Hui KY, Brown RF: A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)- 8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem, 1994, 269, 5241-5248.
37. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, Williams RL: Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell, 2000, 6, 909-919.
38. Warashina A: Mechanism by which wortmannin and LY294002 inhibit catecholamine secretion in the rat adrenal medullary cells. Cell Calcium, 2001, 29, 239-247.
39. Yao R, Cooper GM: Requirement for phosphatidylinositol- 3 kinase in the prevention of apoptosis by nerve growth factor. Science, 1995, 267, 2003-2006